18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Neuroendocrine Tumors
Related studies linked through entity extraction aliases.
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression
- Status
- TERMINATED
- Phase
- PHASE1
Circulating Tumor Cells and Tumor DNA in HCC and NET
- Status
- COMPLETED
- Phase
- N/A
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Pembrolizumab in Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Small Benign Pancreatic Tumors
- Status
- WITHDRAWN
- Phase
- NA
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
- Status
- TERMINATED
- Phase
- PHASE2
SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE3
Identification of Biomarker Profiles GEP-NEN Patients
- Status
- UNKNOWN
- Phase
- N/A
Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
The MetNET-2 Trial
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
The Indol Profile; Exploring the Metabolic Profile of Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- N/A
Study to Measure the Safety of 68Ga-DOTA-TATE PET/CT in the Diagnosis of Tumors Expressing Somatostatin Receptors
- Status
- COMPLETED
- Phase
- N/A
Personalized PRRT of Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Tumors; Safety and Efficacy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2